Thursday, August 1, 2013

It's show me time for the crude oil bulls.....108.93 becomes the "line in the sand"

Thursdays close in crude oil above the 10 day moving average is giving crude oil bulls fresh momentum. What will they do with it? You know how we love Fridays, it tells us so much about the "will" of commercial traders.

September crude oil closed higher on Thursday following Wednesday's Petroleum Inventory that showed declining Midwest diesel supplies. Today's close above the 10 day moving average crossing at 105.80 confirmed that a short term low has been posted. The high range close sets the stage for a steady to higher opening when Friday's night session begins. Stochastics and the RSI are turning neutral to bullish signaling that sideways to higher prices are possible near term. If September extends this week's rally, July's high crossing at 108.93 is the next upside target. Closes below Tuesday's low crossing at 102.67 would confirm that a short term top has been posted. First resistance is today's high crossing at 108.06. Second resistance is July's high crossing at 108.93. First support is Tuesday's low crossing at 102.67. Second support is the 38% retracement level of the April-July rally crossing at 100.27.

The September S&P 500 closed higher on Thursday and posted a new high for the year. The high range close sets the stage for a steady to higher opening when Friday's night session begins trading. Stochastics and the RSI are diverging and remain neutral to bearish hinting that a short term top might be in or is near. Closes below the 20 day moving average crossing at 1673.69 would confirm that a short term top has been posted. If September extends the rally off June's low, upside targets will now be hard to project with the index trading into uncharted territory. First resistance is today's high crossing at 1702.00. Second resistance is unknown with September trading into uncharted territory. First support is the 20 day moving average crossing at 1673.69. Second support is the reaction low crossing at 1670.50.

October gold closed lower on Thursday while extending the trading range of the past eight days. The low range close sets the stage for a steady to lower opening when Friday's night session begins trading. Stochastics and the RSI are bearish hinting that a short term top might be in or is near. Closes below the 20 day moving average crossing at 1292.70 would confirm that a short term top has been posted. If October renews the rally off June's low, the reaction high crossing at 1395.20 is the next upside target. First resistance is last Wednesday's high crossing at 1348.00. Second resistance is the reaction high crossing at 1395.20. First support is the 20 day moving average crossing at 1292.70. Second support is July's low crossing at 1208.50.

September Henry natural gas closed lower on Thursday as it extends the decline off May's high. The mid range close sets the stage for a steady opening on Friday. Stochastics and the RSI are oversold but remain neutral to bearish signaling that sideways to lower prices are possible near term. If September extends the aforementioned decline, the June 2012 low crossing at 3.294 is the next downside target. Closes above the 20 day moving average crossing at 3.630 would confirm that a short term low has been posted. First resistance is the 20 day moving average crossing at 3.630. Second resistance is July's high crossing at 3.833. First support is today's low crossing at 3.341. Second support is the June 2012 low crossing at 3.294.

And how much lower can coffee go? September coffee closed lower on Thursday and below June's low thereby renewing this year's decline. The low range close set the stage for a steady to lower opening on Friday. Stochastics and the RSI are bearish signaling that sideways to lower prices are possible near term. Closes above the 20 day moving average crossing at 122.70 would confirm that a short term low has been posted.

Get our FREE Trading Webinars Today!


How To Find The Right Timing Techniques To Trade Crude Oil

Hello traders everywhere, Adam Hewison here coming to you from the digital studios of MarketClub.

Today I want to share with you how you can trade in the crude oil markets using MarketClub's Trade Triangle technology for timing.

It's a short lesson that visually illustrates how and when you should use this successful timing technique..... 

 
Watch "How To Find The Right Timing Techniques To Trade Crude Oil"


Get our FREE Trading Webinars Today!


Decoding the mystery behind Shell's shale write down

The Market Currents staff at Seeking Alpha is shedding some light on the huge write down by Shell this week. Is the U.S. oil boom over hyped?

Shell's (RDS.A) $2.1B write down on its North American shale oil exploration acknowledges some of its spending there will not prove economically viable, and that hitting its cash flow targets could get tougher. Adding to the mystery is Shell's refusal to identify which shale formation has taken the write down or to explain the charge.

Shale skeptics might take the write down as first evidence the U.S. oil boom is overhyped, but WSJ's James Herron thinks it more likely that Shell has "just failed to get lucky" - Eagle Ford, where Shell has significant operations, is well known for its “sweet spots,” which yield greater volumes of the prized liquids compared with gas.

Start trading crude oil today, here's where you start.


Shell profit plunges after $2.2B charge on North American shale assets

Royal Dutch Shell’s [RDS.A] second quarter 2013 earnings, on a current cost of supplies (CCS) basis (see Note 1), were $2.4 billion compared with $6.0 billion in the same quarter a year ago. Second quarter 2013 earnings included an identified net charge of $2.2 billion after tax, mainly reflecting impairments (see page 6).

Second quarter 2013 CCS earnings excluding identified items (see page 6), were $4.6 billion and included a combined negative impact of $0.7 billion after tax related to the impact of the weakening Australian dollar on a deferred tax liability and the impact of the deteriorating operating environment in Nigeria. Compared to the second quarter 2012, CCS earnings excluding identified items were also impacted by higher operating expenses and depreciation as well as increased exploration well write-offs. Second quarter 2012 CCS earnings excluding identified items were $5.7 billion.

Basic CCS earnings per share excluding identified items decreased by 21% versus the same quarter a year ago.

Cash flow from operating activities for the second quarter 2013 was $12.4 billion, compared with $13.3 billion in the same quarter last year. Excluding working capital movements, cash flow from operating activities for the second quarter 2013 was $8.4 billion, compared with $9.5 billion in the second quarter 2012.

Capital investment for the second quarter 2013 was $11.3 billion. Net capital investment (see Note 1) for the quarter was $10.9 billion.

Total dividends distributed in the quarter were $2.8 billion, of which some $0.8 billion were settled under the Scrip Dividend Programme. During the second quarter some 56.2 million shares were bought back for cancellation for a consideration of $1.9 billion.

Gearing at the end of the second quarter 2013 was 10.3% (see Note 2).

A second quarter 2013 dividend has been announced of $0.45 per ordinary share and $0.90 per American Depositary Share (“ADS”), an increase of 5% compared with the second quarter 2012.

Read the entire Royal Dutch Shell earnings report


Get our FREE Trading Webinars Today!


EIA: Natural Gas Reserves Rose by Almost 10 Percent

U.S. proved crude oil reserve additions in 2011 set a record volumetric increase for the second year in a row, according to U.S. Crude Oil and Natural Gas Proved Reserves, 2011, released today by the U.S. Energy Information Administration (EIA). Natural gas proved reserves rose also, but by less than 2010's record increase. Nevertheless, natural gas reserve additions in 2011 rank as the second largest annual increase since 1977.

"Horizontal drilling and hydraulic fracturing in shale and other tight rock formations continued to increase oil and natural gas reserves," said EIA Administrator Adam Sieminski. "Higher oil prices helped drive record increases in crude oil reserves, while natural gas reserves grew strongly despite slightly lower natural gas prices in 2011."

Proved oil reserves, including both crude oil and lease condensate, increased by 15 percent in 2011 to 29.0 billion barrels, marking the third consecutive annual increase and the highest volume of proved reserves since 1985. Proved reserves in tight oil plays accounted for 3.6 billion barrels (13 percent) of total proved reserves of crude oil and lease condensate in 2011.

Texas recorded the largest volumetric increase in proved oil reserves among individual states, largely because of continuing development in the Permian and Western Gulf basins, while North Dakota had the second largest increase, driven by development activity in the Bakken formation in the Williston Basin.

Natural gas proved reserves, estimated as wet gas that includes natural gas liquids, increased by almost 10 percent in 2010 to 348.8 trillion cubic feet (Tcf), the 13th consecutive annual increase.

Pennsylvania's proved natural gas reserves, which more than doubled in 2010, rose an additional 90 percent in 2011, contributing 41 percent of the overall U.S. increase. Combined, Texas and Pennsylvania added 73 percent of the net increase in U.S. proved wet natural gas reserves in 2011. Proved reserves in shale gas plays accounted for 131.6 trillion cubic feet (38 percent) of total proved reserves of wet natural gas in 2011.

Proved reserves are those volumes of oil and natural gas that geological and engineering data demonstrate with reasonable certainty to be recoverable in future years from known reservoirs under existing economic and operating conditions. EIA's estimates of proved reserves are based on an annual survey of about 1,100 domestic oil and gas well operators.

U.S. Crude Oil and Natural Gas Proved Reserves, 2011 is available at: http://www.eia.gov/naturalgas/crudeoilreserves.

Get our FREE Trading Webinars Today!


Exxon Shares Fall after Big Earnings Miss

ExxonMobil's (XOM) $1.55 EPS, which fell far short of expectations, was the company's lowest EPS since Sept. 2010. (Q2 results)

Earned $6.86B on revenue of $106.47B billion after earning $15.9B on revenue of $127.36B in the year ago quarter when results were inflated by the sale of the Japanese lubricants division; removing those effects, net income fell 19%.

Upstream earnings were $6.3B, down 24.5% year over year, downstream earnings were $396M, down from $6.6B a year ago which included a $5.3 billion gain related to the Japan sale. Oil and gas production fell 1.9%.

Read the entire ExxonMobil earnings report



Get our FREE Trading Webinars Today!


Wednesday, July 31, 2013

Short Covering Gives Crude Oil Bulls Hope.....Bears Still in Charge Here

September crude oil closed higher due to short covering on Wednesday as it consolidates some of the decline off July's high. The high range close sets the stage for a steady to higher opening when Thursday's night session begins. Stochastics and the RSI remain bearish signaling that sideways to lower prices are possible near term. If September extends the decline off July's high, the 38% retracement level of the April-July rally crossing at 100.27 is the next downside target. Closes above the 10 day moving average crossing at 105.82 would confirm that a short term low has been posted. First resistance is the 10 day moving average crossing at 105.82. Second resistance is July's high crossing at 108.93. First support is Tuesday's low crossing at 102.67. Second support is the 38% retracement level of the April-July rally crossing at 100.27.

The September S&P 500 also closed higher on Wednesday. The high range close sets the stage for a steady to higher opening when Thursday's night session begins trading. Stochastics and the RSI are neutral to bearish hinting that a short term top might be in or is near. Closes below the 20 day moving average crossing at 1669.72 would confirm that a short term top has been posted. If September renews the rally off June's low, upside targets will now be hard to project with the index trading into uncharted territory. First resistance is last Tuesday's high crossing at 1695.50. Second resistance is unknown with September trading into uncharted territory. First support is the reaction low crossing at 1670.50. Second support is the 20 day moving average crossing at 1669.73.

September Henry natural gas closed higher due to short covering on Wednesday as it consolidates some of this decline off May's high. The mid range close sets the stage for a steady opening on Thursday. Stochastics and the RSI are oversold but remain neutral to bearish signaling that sideways to lower prices are possible near term. If September extends the aforementioned decline, January's low crossing at 3.350 is the next downside target. Closes above the 20 day moving average crossing at 3.645 would confirm that a short term low has been posted. First resistance is the 20 day moving average crossing at 3.645. Second resistance is July's high crossing at 3.833. First support is Tuesday's low crossing at 3.418. Second support is January's low crossing at 3.350.

October gold closed lower on Wednesday while extending the trading range of the past seven days. The mid range close sets the stage for a steady opening when Thursday's night session begins trading. Stochastics and the RSI are bearish hinting that a short term top might be in or is near. Closes below the 20 day moving average crossing at 1290.30 would confirm that a short term top has been posted. If October renews the rally off June's low, the reaction high crossing at 1395.20 is the next upside target. First resistance is last Wednesday's high crossing at 1348.00. Second resistance is the reaction high crossing at 1395.20. First support is the 20 day moving average crossing at 1290.30. Second support is July's low crossing at 1208.50.

Get our FREE Trading Webinars Today!


10 Reasons Why Obamacare Is Going to Ruin Your Medical Care… and Your Life

By Elizabeth Lee Vliet, M.D.

Of course you've heard of "liar loans"—in the heyday of subprime mortgages, unscrupulous lenders handed out mortgages to practically everyone with a pulse. "So you're saying you make $100,000 a year? Great, check this box titled 'McMansion.'"

We all know how this charade ended. Now Dr. Elizabeth Lee Vliet, M.D., an acclaimed expert on the subject of Obamacare, warns that the delay of the employer mandate by one year will force Americans into a single payer system, raising insurance premiums and encouraging "liar subsidies" that might prove fiscally devastating. Not to mention that under the new health care system, you may well end up dead…

Dan Steinhart
Editor, Casey Research

Obamacare is a hodgepodge of new regulations, requirements, and penalties. I'd like to start by defining three terms, which, while obscure today, should begin to enter our everyday vocabulary as Obamacare continues to take effect:

Health insurance exchanges are the basket of qualified insurance policies that meet the new healthcare law requirements for expanded coverage. These may be set up by the states (many are refusing to do so, due to high cost and fear of bankrupting the state) or the federal government. The Exchanges are supposed to be fully operational by October 1, 2013, but it is questionable whether they will actually be in place by that deadline.

The individual mandate requires that individuals purchase health insurance that meets the new, expanded federal requirements. Individuals who do not comply face a financial penalty. Individuals who fall below minimum income levels will be eligible for taxpayer-funded subsidies to buy health insurance.

The employer mandate requires that businesses with more than 50 full-time employees must provide health insurance for all employees, and that insurance must meet the new standards set forth in the new law. Businesses that do not comply must pay a financial penalty for each employee, which for large companies can run into the millions of dollars annually. This is the piece of Obamacare that has been delayed by one year.

Selective Enforcement

Why delay one component of Obamacare and not the others? More specifically, why delay the employer mandate but not the individual mandate?

To answer that question, we must first understand this fact: Obama wants a single payer healthcare system in the US.

This is not a secret:
Barack Obama, 2003: "I happen to be a proponent of a single payer healthcare system for America, but as all of you know, we may not get there immediately."

Barack Obama, 2007: "But I don't think we will be able to eliminate employer-based coverage immediately. There is potentially going to be some transition time."

These quotes are not taken out of context. Anyone who has been paying attention knows that transitioning to a single-payer system has been Obama's and his cohorts' ultimate goal all along:

Rep. Jan Schakowsky (D-IL), 2009: "Next to me was a guy from the insurance company who then argued against the public option. He said it would not let private insurance companies compete. A public option would put the private insurance companies out of business and lead to single payer. My single payer friends, he was right. The man was right!"

Here, Rep. Schakowsky is suggesting that the "public option" will lead to their desired goal of a single-payer healthcare system. Single-payer proponents no longer use this term, since the public has clearly and consistently opposed it.

The "public option" has been renamed "Medicaid expansion," which serves the public-relations purpose of confusing the public and avoiding calling taxpayer-funded healthcare "single payer."

Jacob S. Hacker (Yale Professor), 2008: "Someone once said to me this is a Trojan Horse for single payer. It's not a Trojan Horse, right? It's right there! I am telling you. We are going to get there. Over time. Slowly. But we are going to move away from reliance on employer-based health insurance, as we should, but we will do it in a way that we are not going to frighten people into thinking they are going to lose their private insurance. We will give them a choice of public or private insurance when they are in the pool. We are going to let them keep their private insurance as long as their employer continues to provide it."
Hacker nicely sums up the underlying goals of Obamacare: not to increase competition or patient choice, but to drive people out of private insurance as a stepping stone to a government-run, single-payer system.

 

Stepping Stone to Single-Payer

Knowing Obama and his cohorts' goals, the purpose behind the delay of the employer mandate seems clearer: to hurry the "transition time" away from employer-based health insurance and to a single-payer system.

By forcing individuals to purchase compliant healthcare plans but not forcing employers to provide those plans, Obama is creating a swell of 10-13 million workers that must enroll in health insurance, but cannot obtain it from their employers. These workers thus have no choice but to use the government-controlled health insurance exchanges, or else pay a financial penalty.

This represents a doubling of the number of workers forced to get health insurance on the exchanges.
Importantly, the IRS has ruled that if workers have access to affordable health insurance through their employer, their dependents are not eligible for taxpayer-funded subsidies on the Obamacare health insurance exchanges.

Now that businesses will not be required to offer health insurance until 2015, workers and their dependents will be eligible for taxpayer-funded subsidies to purchase health insurance on the exchanges.
This will cost taxpayers an estimated $60 billion dollars in 2014 alone to cover the increased costs of subsidies—and the loss of revenue from employer penalties.

This $60 billion figure is before we take into account the "liar subsidies" that will invariably occur now that the administration has quietly removed eligibility verification for taxpayer-funded subsidies.
Community organizers are already being hired around the country to sign people up for the health exchanges. There are no penalties for failing to verify eligibility, and no penalties for signing up people who cannot afford to pay the monthly insurance premiums.

It is set up for disaster, much like the "liar loans" that helped topple the mortgage industry when people were not required to verify their income to qualify for a mortgage.

Remember, by enacting the dual mandates, Obamacare ostensibly was designed to ensure that its costs were borne by businesses, not taxpayers. But when the president decided to enforce only certain portions of the healthcare law and delay others, he shifted the cost of health insurance onto the backs of taxpayers.

This is all on top of the burdensome costs Obamacare has already created. Various studies have projected that private insurance premiums will rise between 20 to 60% in 2014, and some as much as 100%.
How long will the private-insurance market survive with such exploding costs? People will not be able to afford such massive premium increases. That seems to be the point: drive up costs and drive everyone into the arms of government-controlled medical care.

Jeff Smith from Seattle summed it up nicely in a Wall Street Journal letter on June 12:

"I was going to leave my job… to start a business until I shopped around for a healthcare plan: At Group Health, a health-maintenance organization in Seattle, I was given a quote of $842 per month for me and my family. But that would increase to $2,320 starting in January 2014 when Obamacare kicks in—a 276% increase. Why? Because I would be forced to carry coverage I don't want and don't need, such as maternity care. Welcome to the world of socialized medicine, courtesy of the Un-Affordable Care Act."

 

How Obamacare Affects You and Your Medical Care

The delay in the employer mandate is but one of dozens of negative impacts Obamacare will have on your medical services. As an independent physician, I've been discussing these issues with my patients for the past few years, helping them to prepare for what's ahead.
Here are the ten most important points that I tell my patients:
  1. Your private insurance premiums will cost more and more each year.
  1. You will lose the choices and flexibility in health insurance policies that we have had available up until now.
  1. As reimbursements continue to drop, fewer and fewer doctors will take Medicare (for those 65 and older) or Medicaid (people younger than 65).
  1. Fewer doctors accepting Medicare and Medicaid causes an increase in wait times for appointments and a decrease in the numbers and types of specialists available on these plans. Consumers would be wise to line up their doctors now.
  1. Studies from various organizations and states have consistently shown that Medicaid recipients have longer waits for medical care, fewer options for specialists, poorer medical outcomes, and die sooner after surgeries than people with no health insurance at all. Yet an increasing number of Americans will be forced into this second-class medical care.
  1. As more people enter the taxpayer-funded plans (Medicare and Medicaid) instead of paying for private insurance, the costs to provide this increased medical care and medications will escalate, leading to higher taxes.
  1. With no eligibility verifications in place, millions of people who are in the US illegally will be able to access taxpayer-funded medical services, making longer lines, longer wait times, and less money available for medical care for American citizens… unless taxes are increased even more.
  1. Higher expenditures to provide medical services lead to rationing of medical care and treatment options to reduce costs. This is the mandated function of the Independent Payment Advisory Board: to cut costs by deciding which types of medical services to allow… or disallow.

    If you are denied treatment, you have no appeal of IPAB decisions; you are simply out of luck, and possibly out of life. This is a radical departure from the appeals process required for all private health insurance plans. Further, the IPAB is accountable only to President Obama, and cannot be overridden by Congress or the courts. IPAB is designed to have the final word on your health.
  1. Under current regulations, if medical care is denied by Medicare, then a patient is not allowed to pay cash to a Medicare-contracted physician or hospital or other health professional. Patients who need medical care that is denied under Medicare or Medicaid will find themselves having to either: 1) look for an independent physician or hospital (quite rare these days); or 2) go outside the USA for treatment.
  1. Expect a loss of medical privacy. Beginning in 2014, if you participate in government health insurance, your health records will be sent to a centralized federal database, with or without your consent.
The bottom line is that Americans are losing more and more of their medical freedom. By 2015, so many workers will be trapped in the government-run health insurance exchanges that there will be no going back to the private plans we have today. At this rate, single-payer proponents will drive private insurance companies out of business, which has been their intention all along.

Americans need to become far more proactive about taking charge of their health. The healthier you are, the less vulnerable you are to our degrading healthcare system. It's also wise to consider proactively planning for medical treatment options outside the US.

Dr. Vliet will share her thoughts on what Obamacare will do to medical freedom and privacy—and the steps Americans can take now to preserve both—at the upcoming Casey Research Summit 3 Days with Casey, October 4-6 in Tucson, Arizona.

Aside from Dr. Vliet, our blue-ribbon faculty includes keynote speaker Dr. Ron Paul, economic and investment experts Catherine Austin Fitts, Lacy Hunt, James Rickards, John Mauldin, Rick Rule, Chris Martenson, and many more. Most of the speakers have agreed to attend the conference for the entire three days and mingle with the participants.

This is one conference you don't want to miss, but seats are filling up fast.

Get all the details now—if you sign up today, you can still get our $100 first-come, first-save discount.


Also, get our FREE Trading Webinars Today!


Murphy Oil Corp. Reports 2nd Quarter 2013 Earnings

Murphy Oil Corporation (NYSE: MUR) announced today that net income was $402.6 million ($2.12 per diluted share) in the 2013 second quarter, up from $295.4 million ($1.52 per diluted share) in the second quarter 2012. Net income in the 2013 quarter included income from discontinued operations of $70.5 million ($0.37 per diluted share) compared to income from discontinued operations of $4.1 million ($0.02 per diluted share) in the 2012 quarter.

The 2013 income from discontinued operations was primarily generated by an after tax gain of $71.9 million from sale of the Mungo and Monan fields in the United Kingdom during the just completed quarter. Income from continuing operations was $332.1 million ($1.75 per diluted share) for the 2013 second quarter compared to $291.3 million ($1.50 per diluted share) in the same quarter of 2012.

The results of continuing operations improved in 2013 primarily due to higher earnings in the U.S. oil and gas business, which was attributable to growth in oil production in the Eagle Ford Shale area in South Texas.

Read the entire Murphy Oil Corp. earnings report.


Get our FREE Trading Webinars Today!


Phillips 66 2nd Quarter Profit Falls 19 Percent

COT Fund favorite Phillips 66 announces earnings today and states that second quarter earnings plummeted 19 percent as it failed to get the price advantage it got previously from refining U.S. crude oil and dealt with refinery outages.

The refining division's adjusted earnings fell by nearly half partly due to outages at several refineries, including the Sweeny refinery built in Texas in 1942 and the Wood River refinery built in Illinois in 2003. Earnings from the chemicals division fell too.

The company said it earned $958 million, or $1.53 per share, compared with $1.18 billion, or $1.86 per share, a year earlier.

Excluding a gain on asset sales, adjusted earnings were $935 million, or $1.50 per share. Revenue fell 8 percent to $43.95 billion.

Analysts expected the company to earn $1.81 per share on revenue of $42.03 billion, according to FactSet.

Phillips 66 shares fell $1.32, or 2.3 percent, to $57.15 in premarket trading.

Get our FREE Trading Webinars Today!